Table 2.
Demographic characteristics and underlying conditions of patients with COVID-19
| Parameters | NSCP (n = 165) | SCP (n = 71) | χ2 | P value (< 0.05) | ||||
|---|---|---|---|---|---|---|---|---|
| n | % | Mean ± SD | n | % | Mean ± SD | |||
| Sex | ||||||||
| Male | 105 | 63.6 | 53 | 74.6 | ||||
| Female | 60 | 36.4 | 18 | 25.4 | ||||
| Nationality | ||||||||
| Nigerian | 110 | 66.7 | 42 | 59.2 | ||||
| Non-Nigerian | 55 | 33.3 | 29 | 40.8 | ||||
| Age in years | 42.4 ± 17.2 | 52.3 ± 16.9 | ||||||
| 3–23 | 17 | 10.3 | 1 | 1.4 | ||||
| 24–44 | 82 | 49.7 | 25 | 35.2 | ||||
| 45–65 | 53 | 32.1 | 27 | 38.0 | ||||
| 66–86 | 13 | 7.9 | 18 | 25.4 | ||||
| Presence of comorbid disease | ||||||||
| Yes | 33 | 20.0 | 37 | 52.1 | 23.0208 | 0.000 | ||
| No | 132 | 80.0 | 34 | 47.9 | ||||
| Number of comorbid diseases | ||||||||
| None | 132 | 80.0 | 34 | 47.9 | ||||
| One | 22 | 13.3 | 20 | 28.2 | ||||
| Two or more | 11 | 6.7 | 17 | 23.9 | ||||
| Common comorbidities | ||||||||
| Diabetes | 10 | 6.0 | 11 | 15.5 | ||||
| Hypertension | 21 | 12.7 | 27 | 38.0 | ||||
| Asthma | 7 | 4.2 | 2 | 2.8 | ||||
| Mortality | ||||||||
| Yes | 0 | 0 | 6 | 8.5 | 11.100 | 0.000 | ||
| No | 165 | 100 | 65 | 91.5 | ||||
| Comorbidities associated with mortality | ||||||||
| Diabetes and Hypertension | 0 | 0 | 3 | 50 | ||||
| Hypertension and ischemic heart disease | 0 | 0 | 1 | 66.7 | ||||
| Asthma | 0 | 0 | 1 | 16.7 | ||||
| Morbid obesity | 0 | 0 | 1 | 16.7 | ||||
| Malaria parasite | n = 73 | n = 50 | ||||||
| Positive | 1 | 1.4 | 3 | 6.0 | 0.8181 | 0.183 | ||
| Negative | 72 | 98.6 | 47 | 94.0 | ||||
SCP patients with severe COVID-19, NSCP patients with non-severe COVID-19
The P value is provided for comparison between the NSCP and SCP groups